SSRI (SSRI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SSRI Annual Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how SSRI manages its resources, obligations, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Sep 30 2021) (Jun 30 2021) (Mar 31 2021) (Dec 31 2020)
Assets
Cash & cash equivalent1,783.04
Cash And Cash Equivalents0.00
Marketable Securities50.92
Other Short-term Investments0.00
Cash & Short-term Investments1,833.00
Accounts receivable95.77
Trade & Other Current Receivables (IFRS combined total)-
Other Receivables2.40
Notes Receivable, Current25.52
Inventories510.51
Derivatives, Collateral, Regulatory, Deferred4.39
Total loans net29.05
Total Current Assets2,469.30
Equipment/Property/Plant Net0.00
Goodwill net0.00
Long-term investments0.00
Deferred Tax Assets0.00
Discontinued operations, Noncurrent264.12
Other Assets, Noncurrent1,545.86
Total Assets4,279.29
Liabilities
Accounts Payable32.81
Accrued Liabilities, Current98.46
Financial Instruments0.00
Longterm Borrowings0.00
Other Liabilities, Current78.24
Taxes Payable42.72
Discontinued Operation, Liabilities0.00
Total Current Liabilities252.24
Long-term debt0.00
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI0.00
Discontinued Operation, Noncurrent397.27
Noncurrent Provisions238.20
Total Liabilities887.72
Stockholders' Equity
Common Stock Value3,076.46
Retained Earnings / Accumulated Deficit315.11
Common Stockholder's Equity3,391.57
Non-controlling interests & other0.00
Total Stockholder's Equity3,391.57
Liabilities & Stockholder's Equity4,279.29
4 historic quarters locked

Sign in to unlock the full SSRI balance sheet history.

Get the full CSIMarket dataset: Subscribe API Connect Your AI